Federated Hermes, Inc. Pulmonx Corp Transaction History

Federated Hermes, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$7.89 - $13.14 $1,609 - $2,680	204 New	204 $2,000
Q4 2022 Feb 13, 2023	BUY	$4.92 - $17.35 $692,061 - $2.44 Million	140,663 New	140,663 $1.19 Million
Q2 2021 Aug 16, 2021	SELL	$37.61 - $48.0 $1.13 Million - $1.44 Million	-30,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$39.31 - $69.02 $1.18 Million - $2.07 Million	30,000 New	30,000 $2.07 Million

124

30.8M

1.2K

1.2K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.